Optimizing Management of Crohn's Disease Within a Project Management Framework: Results of a Pilot Study

Overview

Journal Inflamm Bowel Dis

Publisher Oxford University Press

Specialty Gastroenterology

Date 2011 Feb 26

PMID 21351218

Citations 15

Authors

Laurie Keefer

Bethany Doerfler

Caroline Artz

Affiliations

Soon will be listed here.

Abstract

Background: Psychotherapy for Crohn's disease (CD) has focused on patients with psychological distress. Another approach to optimize management of CD is to target patients who do not exhibit psychological distress but engage in behaviors that undermine treatment efficacy / increase risk for flare. We sought to determine the feasibility/acceptability and estimate the effects of a program framed around Project Management (PM) principles on CD outcomes.

Methods: Twenty-eight adults with quiescent CD without a history of psychiatric disorder were randomized to PM (n = 16) or treatment as usual (TAU; n = 12). Baseline and follow-up measures were Inflammatory Bowel Disease Questionnaire (IBDQ), Medication Adherence Scale (MAS), Perceived Stress Questionnaire (PSQ), and IBD Self-Efficacy Scale (IBD-SES).

Results: There were significant group × time effects favoring PM on IBDQ-Total Score (F(1) = 15.2, P = 0.001), IBDQ-Bowel (F(1) = 6.5, P = 0.02), and IBDQ-Systemic (F(1) = 9.3, P = 0.007) but not IBDQ-Emotional (F(1) = 1.9, P = ns) or IBDQ-Social (F(1) = 2.4, P = ns). There was a significant interaction effect favoring PM with respect to PSQ (F(1) = 8.4, P = 0.01) and IBD-SES (F(1) = 12.2, P = 0.003). There was no immediate change in MAS (F(1) = 4.3, P = ns). Moderate effect sizes (d > 0.30) were observed for IBDQ total score (d = 0.45), IBDQ bowel health (d = 0.45), and systemic health (d = 0.37). Effect sizes for PSQ (d = 0.13) and IBDSES (d = 0.17) were smaller.

Conclusions: Behavioral programs that appeal to patients who may not seek psychotherapy for negative health behaviors may improve quality of life and potentially disease course and outcomes.

Citing Articles

Engagement in GI Behavioral Health Is Associated with Reduced Portal Messages, Phone Calls, and ED Visits.

Arizmendi B, Craven M, Martinez-Camblor P, Tormey L, Salwen-Deremer J Dig Dis Sci. 2024; 69(6):1939-1947.

PMID: 38622464 DOI: 10.1007/s10620-024-08428-3.

What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials.

King K, McGuinness S, Watson N, Norton C, Chalder T, Czuber-Dochan W Patient Prefer Adherence. 2023; 17:3265-3303.

PMID: 38111690 PMC: 10725835. DOI: 10.2147/PPA.S424024.

A Systematic Review of Self-Management Interventions for Patients with Inflammatory Bowel Disease.

Iizawa M, Hirose L, Nunotani M, Nakashoji M, Tairaka A, Fernandez J Inflamm Intest Dis. 2023; 8(1):1-12.

PMID: 37404383 PMC: 10315013. DOI: 10.1159/000530021.

Development and Validation of a Japanese Version of the Inflammatory Bowel Disease Self-efficacy Scale and Cross-culture Study in Japan and the United States.

Tanaka M, Kawakami A, Sakagami K, Terai T, Fernandez J, Keefer L Inflamm Bowel Dis. 2022; 29(8):1210-1216.

PMID: 36165952 PMC: 10393207. DOI: 10.1093/ibd/izac196.

The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review.

Paulides E, Boukema I, van der Woude C, de Boer N Inflamm Bowel Dis. 2020; 27(5):711-724.

PMID: 32737977 PMC: 8047856. DOI: 10.1093/ibd/izaa144.

References

Miehsler W, Weichselberger M, Offerlbauer-Ernst A, Dejaco C, Reinisch W, Vogelsang H . Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis. 2008; 14(9):1273-80. DOI: 10.1002/ibd.20462. View

Lorig K, Ritter P, Plant K . A disease-specific self-help program compared with a generalized chronic disease self-help program for arthritis patients. Arthritis Rheum. 2005; 53(6):950-7. DOI: 10.1002/art.21604. View

de Rooy E, Toner B, Maunder R, Greenberg G, Baron D, Steinhart A . Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol. 2001; 96(6):1816-21. DOI: 10.1111/j.1572-0241.2001.03877.x. View

Lorig K, Ritter P, Dost A, Plant K, Laurent D, McNeil I . The Expert Patients Programme online, a 1-year study of an Internet-based self-management programme for people with long-term conditions. Chronic Illn. 2008; 4(4):247-56. DOI: 10.1177/1742395308098886. View

Jones M, Wessinger S, Crowell M . Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006; 4(4):474-81. DOI: 10.1016/j.cgh.2005.12.012. View

Swoger J, Loftus Jr E, Tremaine W, Faubion W, Pardi D, Kane S . Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patients. Inflamm Bowel Dis. 2010; 16(11):1912-21. DOI: 10.1002/ibd.21272. View

Ananthakrishnan A, Weber L, Knox J, Skaros S, Emmons J, Lundeen S . Permanent work disability in Crohn's disease. Am J Gastroenterol. 2007; 103(1):154-61. DOI: 10.1111/j.1572-0241.2007.01561.x. View

Kane S . Medication adherence and the physician-patient relationship. Am J Gastroenterol. 2002; 97(7):1853. DOI: 10.1111/j.1572-0241.2002.05872.x. View

Moser G, Tillinger W, Sachs G, Wyatt J, Vogelsang H, Lochs H . Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res. 1996; 40(5):503-9. DOI: 10.1016/0022-3999(95)00581-1. View

10.

Kennedy A, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A . A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease. Health Technol Assess. 2003; 7(28):iii, 1-113. DOI: 10.3310/hta7280. View

11.

Kane S, Dixon L . Adherence rates with infliximab therapy in Crohn's disease. Aliment Pharmacol Ther. 2006; 24(7):1099-103. DOI: 10.1111/j.1365-2036.2006.03092.x. View

12.

Bitton A, Sewitch M, Peppercorn M, Edwardes M, Shah S, Ransil B . Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol. 2003; 98(10):2203-8. DOI: 10.1111/j.1572-0241.2003.07717.x. View

13.

Kane S, Loftus Jr E, Dubinsky M, Sederman R . Disease perceptions among people with Crohn's disease. Inflamm Bowel Dis. 2008; 14(8):1097-101. DOI: 10.1002/ibd.20418. View

14.

Kane S, Cohen R, Aikens J, Hanauer S . Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001; 96(10):2929-33. DOI: 10.1111/j.1572-0241.2001.04683.x. View

15.

Bernstein C, Fried M, Krabshuis J, Cohen H, Eliakim R, Fedail S . World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. 2009; 16(1):112-24. DOI: 10.1002/ibd.21048. View

16.

Janke K, Klump B, Gregor M, Meisner C, Haeuser W . Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11(3):272-86. DOI: 10.1097/01.mib.0000160809.38611.f7. View

17.

Keefer L, Keshavarzian A, Mutlu E . Reconsidering the methodology of "stress" research in inflammatory bowel disease. J Crohns Colitis. 2010; 2(3):193-201. PMC: 3049955. DOI: 10.1016/j.crohns.2008.01.002. View

18.

Marks R, Allegrante J, Lorig K . A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (part II). Health Promot Pract. 2005; 6(2):148-56. DOI: 10.1177/1524839904266792. View

19.

Lorig K, Ritter P, Laurent D, Plant K . Internet-based chronic disease self-management: a randomized trial. Med Care. 2006; 44(11):964-71. DOI: 10.1097/01.mlr.0000233678.80203.c1. View

20.

Levenstein S, Prantera C, Varvo V, Scribano M, Andreoli A, Luzi C . Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol. 2000; 95(5):1213-20. DOI: 10.1111/j.1572-0241.2000.02012.x. View